{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:57Z","timestamp":1790223417562,"version":"4.1.0"},"reference-count":108,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":457,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1111\/bjd.12909","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T12:26:37Z","timestamp":1393244797000},"page":"1226-1236","source":"Crossref","is-referenced-by-count":134,"title":["Prognostic factors, prognostic indices and staging in mycosis fungoides and S\u00e9zary syndrome: where are we now?"],"prefix":"10.1093","volume":"170","author":[{"given":"J.J.","family":"Scarisbrick","sequence":"first","affiliation":[{"name":"Department of Dermatology; University Hospital Birmingham; Birmingham U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.H.","family":"Kim","sequence":"additional","affiliation":[{"name":"Stanford Cancer Centre & School of Medicine; Stanford CA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.","family":"Whittaker","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Guy's and St Thomas' NHS Trust; London U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Wood","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Wisconsin and Middleton VA Medical Center; Madison WI U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.H.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Leiden University Medical Centre; Leiden the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Prince","sequence":"additional","affiliation":[{"name":"Peter MacCallum Cancer Centre and University of Melbourne; Melbourne VIC Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Quaglino","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences; Dermatologic Clinic; University of Torino; Turin Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,6,19]]},"reference":[{"key":"10.1111\/bjd.12909-BIB0001|bjd12909-cit-0001","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0002|bjd12909-cit-0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States - increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"10.1111\/bjd.12909-BIB0003|bjd12909-cit-0003","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-2133.2003.05698.x","article-title":"Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas","volume":"149","author":"Whittaker","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0004|bjd12909-cit-0004","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0005|bjd12909-cit-0005","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamadermatol.2013.5526","article-title":"Changing incidence trends of cutaneous T-cell lymphoma","volume":"149","author":"Korgavkar","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1111\/bjd.12909-BIB0006|bjd12909-cit-0006","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO\/EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0007|bjd12909-cit-0007","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0008|bjd12909-cit-0008","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/archderm.136.4.504","article-title":"Mycosis fungoides: disease evolution and prognosis of 309 Dutch patients","volume":"136","author":"van Doorn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0009|bjd12909-cit-0009","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1001\/archderm.139.7.857","article-title":"Long-term outcome of 525 patients with mycosis fungoides and S\u00e9zary syndrome: clinical prognostic factors and risk for disease progression","volume":"139","author":"Kim","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0010|bjd12909-cit-0010","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0011|bjd12909-cit-0011","doi-asserted-by":"crossref","first-page":"5830","DOI":"10.1002\/cncr.27627","article-title":"Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas","volume":"118","author":"Quaglino","year":"2012","journal-title":"Cancer"},{"key":"10.1111\/bjd.12909-BIB0012|bjd12909-cit-0012","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1263 patients with mycosis fungoides and S\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12909-BIB0013|bjd12909-cit-0013","first-page":"725","article-title":"Report of the committee on staging and classification of cutaneous T-cell lymphomas","volume":"63","author":"Bunn","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/bjd.12909-BIB0014|bjd12909-cit-0014","first-page":"701","article-title":"Status report of 376 mycosis fungoides patients at 4\u00a0years: Mycosis Fungoides Cooperative Group","volume":"63","author":"Lamberg","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"10.1111\/bjd.12909-BIB0015|bjd12909-cit-0015","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0190-9622(99)70079-4","article-title":"Prognostic factor analysis in mycosis fungoides\/S\u00e9zary syndrome","volume":"40","author":"Diamandidou","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0016|bjd12909-cit-0016","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0017|bjd12909-cit-0017","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1200\/JCO.2001.19.3.779","article-title":"Clinical characteristics and outcome of patients with extracutaneous mycosis fungoides","volume":"19","author":"Coninck","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0018|bjd12909-cit-0018","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0019|bjd12909-cit-0019","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1067\/mjd.2002.118538","article-title":"Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas","volume":"46","author":"Vonderheid","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0020|bjd12909-cit-0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood.V97.3.624","article-title":"Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma","volume":"97","author":"Scarisbrick","year":"2001","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0021|bjd12909-cit-0021","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-4632.2009.03771.x","article-title":"Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma","volume":"48","author":"Vidulich","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0022|bjd12909-cit-0022","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1067\/mjd.2001.117722","article-title":"A modified staging classification for cutaneous T-cell lymphoma","volume":"45","author":"Kashani-Sabet","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0023|bjd12909-cit-0023","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinicopathologic factors in cutaneous T-cell lymphoma","volume":"127","author":"Marti","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0024|bjd12909-cit-0024","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0190-9622(99)70491-3","article-title":"Prognosis in cutaneous T-cell lymphoma by skin stage: long-term survival in 489 patients","volume":"40","author":"Zackheim","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0025|bjd12909-cit-0025","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0190-9622(97)70212-3","article-title":"Prognostic factors and evaluation of mycosis fungoides and S\u00e9zary syndrome","volume":"37","author":"Toro","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0026|bjd12909-cit-0026","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/archderm.135.10.1204","article-title":"Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept","volume":"135","author":"Schmid","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0027|bjd12909-cit-0027","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.138.1.42","article-title":"Quantifying skin disease burden in mycosis fungoides-type cutaneous T-cell lymphomas: the severity-weighted assessment tool (SWAT)","volume":"138","author":"Stevens","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0028|bjd12909-cit-0028","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1200\/JCO.2001.19.2.376","article-title":"Pivotal phase III trial of two dose levels of denileukin diftitox for the treatment of cutaneous T-cell lymphoma","volume":"19","author":"Olsen","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0029|bjd12909-cit-0029","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0030|bjd12909-cit-0030","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical end points and response criteria in mycosis fungoides and S\u00e9zary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0031|bjd12909-cit-0031","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/bjd.12403","article-title":"How big is your hand and should you use it to score skin in cutaneous T-cell lymphoma?","volume":"69","author":"Scarisbrick","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0032|bjd12909-cit-0032","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","article-title":"The changing survival of patients with mycosis fungoides","volume":"85","author":"Weinstock","year":"1999","journal-title":"Cancer"},{"key":"10.1111\/bjd.12909-BIB0033|bjd12909-cit-0033","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","article-title":"Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Suzuki","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.12909-BIB0034|bjd12909-cit-0034","first-page":"191","article-title":"Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients","volume":"138","author":"Doorn","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0035|bjd12909-cit-0035","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1001\/archderm.144.6.738","article-title":"Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma","volume":"144","author":"Gerami","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0036|bjd12909-cit-0036","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.jaad.2009.03.014","article-title":"Folliculotropic mycosis fungoides: clinicopathological features and outcome in a series of 20 cases","volume":"62","author":"Muniesa","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0037|bjd12909-cit-0037","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/archdermatol.2010.101","article-title":"Folliculotropic mycosis fungoides: single-center study and systematic review","volume":"146","author":"Lehman","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0038|bjd12909-cit-0038","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jaad.2010.05.041","article-title":"Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features","volume":"65","author":"Abbott","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0039|bjd12909-cit-0039","first-page":"630","article-title":"Lymphomatoid papulosis in association with mycosis fungoides: a study of 15 cases","volume":"139","author":"Basarab","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0040|bjd12909-cit-0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/1042819021000054652","article-title":"S\u00e9zary syndrome and related variants of classic cutaneous T-cell lymphoma. A descriptive and prognostic clinicopathologic study of 29 cases","volume":"44","author":"Marti","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/bjd.12909-BIB0041|bjd12909-cit-0041","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archderm.140.9.1057","article-title":"Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas","volume":"140","author":"Tancr\u00e8de-Bohin","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0042|bjd12909-cit-0042","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/jid.2011.351","article-title":"High soluble CD30, CD25, and IL-6 may identify patients with worse survival in CD30+ cutaneous lymphomas and early mycosis fungoides","volume":"132","author":"Kadin","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0043|bjd12909-cit-0043","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/archderm.1996.03890250052009","article-title":"Increased serum concentration of the soluble interleukin-2 receptor in cutaneous T-cell lymphoma. Clinical and prognostic implications","volume":"132","author":"Wasik","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0044|bjd12909-cit-0044","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10428194.2013.790541","article-title":"Prognostic factors and risk stratification in early mycosis fungoides","volume":"55","author":"Vonderheid","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/bjd.12909-BIB0045|bjd12909-cit-0045","first-page":"265","article-title":"Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study","volume":"132","author":"Salhany","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12909-BIB0046|bjd12909-cit-0046","first-page":"2212","article-title":"Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas","volume":"95","author":"Vergier","year":"2000","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0047|bjd12909-cit-0047","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/PAS.0b013e3181bf677d","article-title":"CD30 expression and proliferative fraction in non-transformed mycosis fungoides","volume":"33","author":"Edinger","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/bjd.12909-BIB0048|bjd12909-cit-0048","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1034\/j.1600-0560.2000.027008392.x","article-title":"Co-expression of CD56 and CD30 in lymphomas with primary presentation in the skin: clinicopathologic, immunohistochemical and molecular analyses of seven cases","volume":"27","author":"Natkunam","year":"2000","journal-title":"J Cutan Pathol"},{"key":"10.1111\/bjd.12909-BIB0049|bjd12909-cit-0049","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1182\/blood-2012-10-461848","article-title":"CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study","volume":"121","author":"Hu","year":"2013","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0050|bjd12909-cit-0050","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2001.19.8.2179","article-title":"Natural killer\/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course","volume":"19","author":"Mraz-Gernhard","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0051|bjd12909-cit-0051","first-page":"1158","article-title":"Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders","volume":"23","author":"Kadin","year":"2009","journal-title":"Oncology"},{"key":"10.1111\/bjd.12909-BIB0052|bjd12909-cit-0052","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1365-2133.2009.09301.x","article-title":"Clinical characteristic and course of CD8+ cytotoxic variant of mycosis fungoides","volume":"161","author":"Nikolaou","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0053|bjd12909-cit-0053","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/leu.2011.237","article-title":"Regulatory T cells and immunodeficiency in mycosis fungoides and S\u00e9zary syndrome","volume":"26","author":"Krejsgaard","year":"2012","journal-title":"Leukemia"},{"key":"10.1111\/bjd.12909-BIB0054|bjd12909-cit-0054","first-page":"15","article-title":"The regulatory T-cell phenotype in progressive mycosis fungoides","volume":"143","author":"Hallermann","year":"2008","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1111\/bjd.12909-BIB0055|bjd12909-cit-0055","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1080\/10428190802064917","article-title":"Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma","volume":"49","author":"Capriotti","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/bjd.12909-BIB0056|bjd12909-cit-0056","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1038\/jid.2009.175","article-title":"FOXP3+CD25\u2212 tumor cells with regulatory function in S\u00e9zary syndrome","volume":"129","author":"Heid","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0057|bjd12909-cit-0057","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0058|bjd12909-cit-0058","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/sj.leu.2404182","article-title":"Paucity of FOXP3+ cells in skin and peripheral blood distinguishes S\u00e9zary syndrome from other cutaneous T-cell lymphomas","volume":"20","author":"Klemke","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/bjd.12909-BIB0059|bjd12909-cit-0059","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1600-0560.2009.01381.x","article-title":"Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis","volume":"37","author":"Wada","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1111\/bjd.12909-BIB0060|bjd12909-cit-0060","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1038\/sj.leu.2404913","article-title":"FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival","volume":"21","author":"Gjerdrum","year":"2007","journal-title":"Leukemia"},{"key":"10.1111\/bjd.12909-BIB0061|bjd12909-cit-0061","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.jid.5700371","article-title":"Lack of suppressive CD4+CD25+FOXP3+ T cells in advanced stages of primary cutaneous T-cell lymphoma","volume":"126","author":"Tiemessen","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0062|bjd12909-cit-0062","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/DAD.0b013e31823062db","article-title":"FOXP3 in sequential biopsies of progressive mycosis fungoides","volume":"34","author":"Fried","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1111\/bjd.12909-BIB0063|bjd12909-cit-0063","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1200\/JCO.2001.19.23.4322","article-title":"CD8+ T cells in cutaneous T-cell lymphoma: expression of cytotoxic proteins, Fas ligand, and killing inhibitory receptors and their relationship with clinical behavior","volume":"19","author":"Vermeer","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0064|bjd12909-cit-0064","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0190-9622(95)90067-5","article-title":"CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides","volume":"32","author":"Hoppe","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0065|bjd12909-cit-0065","first-page":"2682","article-title":"Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?","volume":"7","author":"Ni","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12909-BIB0066|bjd12909-cit-0066","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaad.2012.05.035","article-title":"The Fas apoptotic pathway in cutaneous T-cell lymphomas: frequent expression of phenotypes associated with resistance to apoptosis","volume":"67","author":"Stutz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0067|bjd12909-cit-0067","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0068|bjd12909-cit-0068","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1182\/blood-2009-05-220111","article-title":"Monocytes promote tumor cell survival in T-cell lymphoproliferative disorders and are impaired in their ability to differentiate into mature dendritic cells","volume":"114","author":"Wilcox","year":"2009","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0069|bjd12909-cit-0069","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","article-title":"Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma","volume":"68","author":"Sugaya","year":"2012","journal-title":"J Dermatol Sci"},{"key":"10.1111\/bjd.12909-BIB0070|bjd12909-cit-0070","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12909-BIB0071|bjd12909-cit-0071","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/bjd.12909-BIB0072|bjd12909-cit-0072","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2005-07-2813","article-title":"Quantitative PCR on 5 genes reliably identifies CTCL patients with 5% to 99% circulating tumor cells with 90% accuracy","volume":"107","author":"Nebozhyn","year":"2006","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0073|bjd12909-cit-0073","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.jid.5700029","article-title":"Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides - cutaneous T cell lymphoma","volume":"126","author":"Wong","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0074|bjd12909-cit-0074","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1182\/blood-2010-09-305128","article-title":"High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS\/RAF\/MEK signaling cascade","volume":"117","author":"Kiessling","year":"2011","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0075|bjd12909-cit-0075","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/archdermatol.2010.200","article-title":"Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression","volume":"146","author":"Samimi","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.12909-BIB0076|bjd12909-cit-0076","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajh.21960","article-title":"Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and S\u00e9zary syndrome","volume":"86","author":"Wada","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1111\/bjd.12909-BIB0077|bjd12909-cit-0077","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetin\u00f6zman","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1111\/bjd.12909-BIB0078|bjd12909-cit-0078","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/jid.2010.97","article-title":"TCR\u03b3-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in S\u00e9zary syndrome","volume":"130","author":"Fierro","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0079|bjd12909-cit-0079","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1023\/A:1008397323199","article-title":"Prognostic factors in S\u00e9zary syndrome: a multivariate analysis of clinical, haematological and immunological features","volume":"9","author":"Bernengo","year":"1998","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.12909-BIB0080|bjd12909-cit-0080","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0889-8588(03)00120-5","article-title":"The S\u00e9zary syndrome: hematologic criteria","volume":"17","author":"Vonderheid","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/bjd.12909-BIB0081|bjd12909-cit-0081","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1309\/U1Y6-J4AG-5M4M-7AYV","article-title":"Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood","volume":"115","author":"Jones","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/bjd.12909-BIB0082|bjd12909-cit-0082","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1365-2133.2001.04014.x","article-title":"The relevance of the CD4+CD26\u2212 subset in the identification of circulating S\u00e9zary cells","volume":"144","author":"Bernengo","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0083|bjd12909-cit-0083","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2005.06.001","article-title":"Association of change in clinical status and change in the percentage of the CD4+CD26\u2212 lymphocyte population in patients with S\u00e9zary syndrome","volume":"53","author":"Introcaso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0084|bjd12909-cit-0084","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1309\/05GFG3LY3VYCDMEY","article-title":"The usefulness of CD26 in flow cytometric analysis of peripheral blood in S\u00e9zary syndrome","volume":"129","author":"Kelemen","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/bjd.12909-BIB0085|bjd12909-cit-0085","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2133.1996.tb07941.x","article-title":"Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases","volume":"134","author":"Novelli","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0086|bjd12909-cit-0086","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome)","volume":"155","author":"Wong","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1111\/bjd.12909-BIB0087|bjd12909-cit-0087","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/bjd.12578","article-title":"Lessons learned from gene expression profiling of cutaneous T-cell lymphoma","volume":"169","author":"Dulmage","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0088|bjd12909-cit-0088","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0089|bjd12909-cit-0089","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1158\/1078-0432.CCR-07-0610","article-title":"Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma\/mycosis fungoides","volume":"14","author":"Chong","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12909-BIB0090|bjd12909-cit-0090","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1046\/j.1523-1747.2003.12496.x","article-title":"Microsatellite instability is associated with hypermethylation of the hMLH1 gene and reduced gene expression in mycosis fungoides","volume":"121","author":"Scarisbrick","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0091|bjd12909-cit-0091","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":"Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides","volume":"130","author":"Salgado","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0092|bjd12909-cit-0092","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1038\/jid.2012.117","article-title":"A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides","volume":"132","author":"Kester","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0093|bjd12909-cit-0093","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1158\/1078-0432.CCR-09-2879","article-title":"Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma","volume":"16","author":"Litvinov","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12909-BIB0094|bjd12909-cit-0094","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/sj.leu.2405044","article-title":"S\u00e9zary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3","volume":"22","author":"Booken","year":"2008","journal-title":"Leukemia"},{"key":"10.1111\/bjd.12909-BIB0095|bjd12909-cit-0095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"S\u00e9zary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0096|bjd12909-cit-0096","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of S\u00e9zary cells: relevance for the diagnosis and follow-up of S\u00e9zary syndrome","volume":"122","author":"Poszepczynska-Guign\u00e9","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0097|bjd12909-cit-0097","first-page":"7122","article-title":"Aberrant expression of T-plastin in S\u00e9zary cells","volume":"63","author":"Su","year":"2003","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12909-BIB0098|bjd12909-cit-0098","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2133.2009.09587.x","article-title":"T-plastin (PLS3) gene expression differentiates S\u00e9zary syndrome from mycosis fungoides and inflammatory skin diseases and can serve as a biomarker to monitor disease progression","volume":"162","author":"Tang","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0099|bjd12909-cit-0099","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/jid.2012.106","article-title":"Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma","volume":"132","author":"Jones","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12909-BIB0100|bjd12909-cit-0100","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood.V83.5.1165.1165","article-title":"Prognostic factors in aggressive non-Hodgkin's lymphoma: who has \u2018high-risk\u2019 disease?","volume":"83","author":"Shipp","year":"1994","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0101|bjd12909-cit-0101","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-C\u00e9ligny","year":"2004","journal-title":"Blood"},{"key":"10.1111\/bjd.12909-BIB0102|bjd12909-cit-0102","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1016\/S0140-6736(05)63605-7","article-title":"Cutaneous T-cell lymphoma severity index and T-cell gene rearrangement","volume":"350","author":"Dippel","year":"1997","journal-title":"Lancet"},{"key":"10.1111\/bjd.12909-BIB0103|bjd12909-cit-0103","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2133.2005.06676.x","article-title":"Prognostic factors and prediction of prognosis by the CTCL Severity Index in mycosis fungoides and S\u00e9zary syndrome","volume":"153","author":"Klemke","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12909-BIB0104|bjd12909-cit-0104","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jaad.2009.01.044","article-title":"Validity assessment of the cutaneous T-cell lymphoma severity index to predict prognosis in advanced mycosis fungoides\/S\u00e9zary syndrome","volume":"64","author":"Evans","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.12909-BIB0105|bjd12909-cit-0105","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.ejca.2013.04.018","article-title":"A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and S\u00e9zary syndrome","volume":"49","author":"Benton","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12909-BIB0106|bjd12909-cit-0106","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejca.2006.01.025","article-title":"EORTC consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome","volume":"42","author":"Trautinger","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12909-BIB0107|bjd12909-cit-0107","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1200\/JCO.2010.29.3241","article-title":"Allogeneic haematopoietic cell transplantation for patients with mycosis fungoides and S\u00e9zary syndrome","volume":"28","author":"Duarte","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12909-BIB0108|bjd12909-cit-0108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/10428194.2013.809081","article-title":"Are we close to a prognostic index for cutaneous T cell lymphoma?","volume":"55","author":"Prince","year":"2014","journal-title":"Leuk Lymphoma"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12909","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12909\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:08:56Z","timestamp":1676365736000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/170\/6\/1226\/6614658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12909","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}